These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9722032

  • 1. Antithrombin III and sepsis.
    Mammen EF.
    Intensive Care Med; 1998 Jul; 24(7):649-50. PubMed ID: 9722032
    [No Abstract] [Full Text] [Related]

  • 2. Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective?
    Iba T, Thachil J.
    Intensive Care Med; 2016 Jul; 42(7):1193-4. PubMed ID: 27143022
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic modalities to ameliorate endotoxin induced DIC in the rats.
    Bahrami S, Paul E, Redl H, Schlag G.
    Prog Clin Biol Res; 1989 Jul; 308():977-82. PubMed ID: 2780743
    [No Abstract] [Full Text] [Related]

  • 4. [The clinical efficacy of antithrombin III concentrate in infections complicated by DIC].
    Kobayashi H, Kawai S, Oshitani H, Tamakuma S, Hayasaka H, Akiyama M, Nakamura T, Hashimoto I, Sawada Y, Takebe K.
    Kansenshogaku Zasshi; 1985 Nov; 59(11):1121-34. PubMed ID: 3938461
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Antithrombin III in intensive therapy].
    Baudo F, Caimi TM, Decataldo F, Calori G.
    Minerva Anestesiol; 1999 Nov; 65(1-2 Suppl 1):71-6. PubMed ID: 10206028
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation.
    von Kries R, Stannigel H, Göbel U.
    Eur J Pediatr; 1985 Jul; 144(2):191-4. PubMed ID: 4043133
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation.
    Vinazzer H.
    Semin Thromb Hemost; 1989 Jul; 15(3):347-52. PubMed ID: 2688106
    [No Abstract] [Full Text] [Related]

  • 10. Perspectives for the future.
    Mammen EF.
    Intensive Care Med; 1993 Jul; 19 Suppl 1():S29-34. PubMed ID: 8227736
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T, Saitoh D, Gando S, Thachil J.
    Thromb Res; 2015 May; 135(5):897-901. PubMed ID: 25784136
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Antithrombin III in the treatment of disseminated intravascular coagulation].
    Nordgaard-Andersen I, Madsen JR.
    Ugeskr Laeger; 1997 Feb 03; 159(6):730-1. PubMed ID: 9045459
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.